Publication | Closed Access

PP-8-3 Double-blind trial in postmenopausal (PMP) women with advanced breast cancer (ABC) showing a dose-effect and superiority of 2.5 mg letrozole over megestrol acetate (MA)

Megestrol AcetateAdvanced Breast CancerOncologyPp-8-3 Double-blind TrialBreast OncologyMedicineClinical TrialsGynecologyBreast CancerMenopausePharmacotherapyMenopause Hormone TherapyCancer TreatmentPharmacologyRadiation OncologyEndocrine-related CancerHealth Sciences